Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sabbagh

Showing results (11-20 of 330) with videos related to

Pageof 33
Sort By:
Neurology|July 9, 2008
Detecting Alzheimer disease before it happens: The key to prevention?Joseph Quinn, Marwan N Sabbagh
Drugs & Aging|August 15, 2013
Successes and failures for drugs in late-stage development for Alzheimer's diseaseCamryn Berk, Marwan N Sabbagh
Nature Reviews. Neurology|January 10, 2023
Biomarker-based diagnosis of preclinical Alzheimer disease: time for the clinic?Marwan N Sabbagh, Boris DeCourt
Panminerva Medica|December 20, 2007
Pathological correlates of cognitive decline in Alzheimer's diseaseK Thind, M N Sabbagh
Neurology|January 2, 2008
Interactions of stroke, nonsteroidal anti-inflammatory drugs, and APOE status in dementia riskJoseph Rogers, Marwan N Sabbagh
Alzheimer'S & Dementia (New York, N. Y.)|January 22, 2025
Perspective: Minimally clinically important "symptomatic" benefit associated with disease modification resulting from anti-amyloid immunotherapyJohn Alam, Marwan N Sabbagh
Expert Opinion on Investigational Drugs|August 25, 2022
COR388 (atuzaginstat): an investigational gingipain inhibitor for the treatment of Alzheimer diseaseMarwan N Sabbagh, Boris Decourt
Neurology and Therapy|December 14, 2019
Peripheral Biomarkers for Alzheimer's Disease: Update and ProgressMarwan N Sabbagh, Kaj Blennow
Journal of Alzheimer'S Disease : JAD|March 16, 2011
BACE1 as a potential biomarker for Alzheimer's diseaseBoris Decourt, Marwan N Sabbagh
Neurology and Therapy|May 23, 2015
Florbetaben for PET Imaging of Beta-Amyloid Plaques in the BrainDanielle Richards, Marwan N Sabbagh
Pageof 33

Showing results (11-20 of 330) with videos related to

Sort By:
Pageof 33
Neurology|July 9, 2008
Detecting Alzheimer disease before it happens: The key to prevention?Joseph Quinn, Marwan N Sabbagh
Drugs & Aging|August 15, 2013
Successes and failures for drugs in late-stage development for Alzheimer's diseaseCamryn Berk, Marwan N Sabbagh
Nature Reviews. Neurology|January 10, 2023
Biomarker-based diagnosis of preclinical Alzheimer disease: time for the clinic?Marwan N Sabbagh, Boris DeCourt
Panminerva Medica|December 20, 2007
Pathological correlates of cognitive decline in Alzheimer's diseaseK Thind, M N Sabbagh
Neurology|January 2, 2008
Interactions of stroke, nonsteroidal anti-inflammatory drugs, and APOE status in dementia riskJoseph Rogers, Marwan N Sabbagh
Alzheimer'S & Dementia (New York, N. Y.)|January 22, 2025
Perspective: Minimally clinically important "symptomatic" benefit associated with disease modification resulting from anti-amyloid immunotherapyJohn Alam, Marwan N Sabbagh
Expert Opinion on Investigational Drugs|August 25, 2022
COR388 (atuzaginstat): an investigational gingipain inhibitor for the treatment of Alzheimer diseaseMarwan N Sabbagh, Boris Decourt
Neurology and Therapy|December 14, 2019
Peripheral Biomarkers for Alzheimer's Disease: Update and ProgressMarwan N Sabbagh, Kaj Blennow
Journal of Alzheimer'S Disease : JAD|March 16, 2011
BACE1 as a potential biomarker for Alzheimer's diseaseBoris Decourt, Marwan N Sabbagh
Neurology and Therapy|May 23, 2015
Florbetaben for PET Imaging of Beta-Amyloid Plaques in the BrainDanielle Richards, Marwan N Sabbagh
Pageof 33